Literature DB >> 26398010

Validation protocols for blood pressure-measuring devices: status quo and development needs.

Beate Beime1, Cornelia Deutsch, Timothy Gomez, Thomas Zwingers, Thomas Mengden, Peter Bramlage.   

Abstract

Hypertension is a major risk factor for cardiovascular morbidity and mortality. Therefore, blood pressure self-measuring devices have emerged as valuable tools in patient care and the accuracy of these instruments is of fundamental importance. For this reason, several validation procedures for assessing the efficacy of blood pressure monitoring devices have been developed, including protocols by the Association for the Advancement of Medical Instrumentation, the British Hypertension Society, the German Hypertension League (Prüfsiegelprotokoll), and the International Protocol of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. In the past, most of the protocols have been reviewed and modified because of experiences gained during the validation studies carried out. However, each shows distinct differences, that is number and characteristics of patients required, blood pressure ranges, and the length of the validation procedure, which may result in unique advantages and/or limitations associated with their use. The continued standardization and evolution of these guidelines is essential to ensure the efficacy of blood pressure-measuring devices marketed for clinical and home use. Here, we aimed to compare four currently used validation protocols and to initiate a discussion on potential future improvements.

Entities:  

Mesh:

Year:  2016        PMID: 26398010     DOI: 10.1097/MBP.0000000000000150

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  5 in total

1.  Baseline check of blood pressure readings of an automated device in severe pre-eclampsia and healthy normotensive pregnancy.

Authors:  Nnabuike C Ngene; Jagidesa Moodley
Journal:  Pregnancy Hypertens       Date:  2018-03-01       Impact factor: 2.899

Review 2.  New Approaches to Evaluating and Monitoring Blood Pressure.

Authors:  Elizabeth M Goldberg; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

3.  Similar cardiometabolic effects of high- and moderate-intensity training among apparently healthy inactive adults: a randomized clinical trial.

Authors:  Robinson Ramírez-Vélez; Alejandra Tordecilla-Sanders; Luis Andrés Téllez-T; Diana Camelo-Prieto; Paula Andrea Hernández-Quiñonez; Jorge Enrique Correa-Bautista; Antonio Garcia-Hermoso; Rodrigo Ramirez-Campillo; Mikel Izquierdo
Journal:  J Transl Med       Date:  2017-05-30       Impact factor: 5.531

Review 4.  Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum.

Authors:  Sang-Hyun Ihm; Jae-Hyeong Park; Jang Young Kim; Ju-Han Kim; Kwang-Il Kim; Eun Mi Lee; Hae-Young Lee; Sungha Park; Jinho Shin; Cheol-Ho Kim
Journal:  Clin Hypertens       Date:  2022-10-01

Review 5.  Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization.

Authors:  James E Sharman; Alberto P Avolio; Johannes Baulmann; Athanase Benetos; Jacques Blacher; C Leigh Blizzard; Pierre Boutouyrie; Chen-Huan Chen; Phil Chowienczyk; John R Cockcroft; J Kennedy Cruickshank; Isabel Ferreira; Lorenzo Ghiadoni; Alun Hughes; Piotr Jankowski; Stephane Laurent; Barry J McDonnell; Carmel McEniery; Sandrine C Millasseau; Theodoros G Papaioannou; Gianfranco Parati; Jeong Bae Park; Athanase D Protogerou; Mary J Roman; Giuseppe Schillaci; Patrick Segers; George S Stergiou; Hirofumi Tomiyama; Raymond R Townsend; Luc M Van Bortel; Jiguang Wang; Siegfried Wassertheurer; Thomas Weber; Ian B Wilkinson; Charalambos Vlachopoulos
Journal:  Eur Heart J       Date:  2017-10-01       Impact factor: 29.983

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.